Abstract Details

Title Pediatric Multiple Sclerosis in the United Arab Emirates: Characteristics From a Multi-Center Study and Global Comparison

Topic Multiple Sclerosis

Presentation(s) P4 - (-)

Poster/Presentation
Number 348

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Fatima Y. Ismail, MD (United Arab Emirates University) PRESENTER	No disclosure on file
Eliza M. Gordon-Lipkin, MD (Kennedy Krieger Institute)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Taoufik Alsaadi, MD, FAAN (American Center for Psychiatry & Neurology ( ACPN))	Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Alsaadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Alsaadi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GSK. The institution of Dr. Alsaadi has received research support from Novartis. The institution of Dr. Alsaadi has received research support from Abbvie. The institution of Dr. Alsaadi has received research support from Pfizer.
	No disclosure on file
Nicoline Schiess, MD (WHO)	Dr. Schiess has received personal compensation for serving as an employee of World Health Organization .

��ɫ��